WAY-255348

W-255348 is an effective non-steroidal progesterone receptor (PR) antagonist that acquires antagonist activity by binding to and subsequently blocking progesterone induced nuclear accumulation, phosphorylation, and PR promoter interactions. WAY-255348 can be used in the research of reproductive disorders or PR-positive breast cancer[1].

Product Specifications

CAS Number

[872141-23-6]

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Progesterone Receptor

Related Pathways

Vitamin D Related/Nuclear Receptor

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Cancer; Endocrinology

Smiles

N#CC1=CC=C(N1C)C2=CC3=C(NC(C3(C)C)=O)C(F)=C2

Molecular Formula

C16H14FN3O

Molecular Weight

283.30

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]J. Med. Chem., 2008, 51 (6), pp 1861-1873 "Design, Synthesis, and SAR of New Pyrrole-Oxindole Progesterone Receptor Modulators Leading to 5- (7-Fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl) -1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348) "|[2]Yudt MR, et al. Discovery of a novel mechanism of steroid receptor antagonism: WAY-255348 modulates progesterone receptor cellular localization and promoter interactions. Biochem Pharmacol. 2011 Dec 1;82 (11) :1709-19.